A new procedure for registering veterinary drugs will come into force in 2026.

Since 2022, ROSSELKHOZNADZOR has already begun transitioning to an electronic registration format, allowing producers to submit applications online , significantly reducing processing time. However, paper applications remained available, which slowed down the process.

Under the new regulation, manufacturers must use a single platform for submitting documents with an enhanced, qualified electronic signature, ensuring a high level of data security. The benefits of the new approach include simplified processes, reduced waiting times, increased transparency, and reduced paper use, which in turn contributes to environmental protection.

Manufacturers are advised to familiarize themselves with the new requirements in advance and ensure they have a qualified electronic signature to ensure efficient registration.